書籍情報から探す
An example of potential impacts of ASENT and JSNT for therapy development : 2DG in the pipeline for epilepsy and TBI
Thomas Sutula*
*Neurology, University of Wisconsin ; American Society of Experimental Neuro Therapeutics ; Chief Scientific Officer, Neurogenomex, Inc.
Neurological Therapeutics 36 (3) 123-123, 2019.
*Neurology, University of Wisconsin ; American Society of Experimental Neuro Therapeutics ; Chief Scientific Officer, Neurogenomex, Inc.
Neurological Therapeutics 36 (3) 123-123, 2019.
- アブストラクト: 従量制は110円(税込)、基本料金制は基本料金に含まれます。
- 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
Corticosteroid therapy for acute attacks in hereditary neuropathy with liability to pressure palsies - A case report
Misako Kaido*, Yuichi Yamada**, Yoshihito Yuasa*
*Department of Neurology, Sakai City Medical Center, **Department of Internal Medicine, Sakai City Medical Center
Neurological Therapeutics 36 (3) 321-324, 2019.
*Department of Neurology, Sakai City Medical Center, **Department of Internal Medicine, Sakai City Medical Center
Neurological Therapeutics 36 (3) 321-324, 2019.
- アブストラクト: 従量制は110円(税込)、基本料金制は基本料金に含まれます。
- 全文ダウンロード: 従量制、基本料金制の方共に770円(税込) です。